Genesis Study
100+
Yuklanmalar
Hamma uchun
info
Bu ilova haqida
A 12-month randomised, double-blind, controlled, international multicentre trial comparing changes in cigarette consumption after switching to high or low nicotine strength e-cigarettes in smokers with Schizophrenia spectrum disorders. This will be a multicenter, 12-months prospective trial, utilizing a randomized, double-blind, 2-arm parallel, switching design to compare effectiveness, tolerability, acceptability, and pattern of use between high (JUUL 5% nicotine) and low nicotine strength devices (JUUL 1.5% nicotine) in adult smokers with schizophrenia spectrum disorders. The study will take place at 5 sites: 1 in the UK (London) and possibly 4 in Italy.
Oxirgi yangilanish
Xavfsizlik — dastur ishlab chiquvchilar maʼlumotlaringizni qanday jamlashi va ulashishini tushunishdan boshlanadi. Maʼlumotlar maxfiyligi va xavfsizlik amaliyotlari ilovadan foydalanish, hudud va yoshga qarab farq qilishi mumkin. Bu axborot dastur ishlab chiquvchi tomonidan taqdim etilgan va keyinchalik yangilanishi mumkin.
Tashqi hamkorlarga hech qanday axborot ulashilmagan
Dastur ishlab chiquvchilar axborot ulashilishini qanday aytishi haqida batafsil
Ushbu ilova quyidagi axborot turlarini toʻplashi mumkin
Ilova axboroti va unumdorlik
Maʼlumotlar uzatish vaqtida shifrlanadi
Maʼlumotlarni oʻchirishni soʻrashingiz mumkin
Nima yangiliklar
Performance improvements.
Ilova yuzasidan yordam
Dasturchi haqida
ECLAT SRL
diasmoke@eclatrbc.it
VIA SANTA SOFIA 89
95123 CATANIA
Italy
+44 7886 420447
